VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels

Pathology Research and Practice

Volumn 201, Issue 2, 2005, Pages 93-99

  Filho, Adhemar Longatto ^a,b   Martins, Albino ^a   Araújo Costa, Sandra Maria ^a   Schmitt, Fernando C ^c,d  

^a UNIVERSITY OF MINHO   (Portugal)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c University of Porto   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Angiogenesis; Breast cancer; Lymphangiogenesis; Vascular endothelial growth factor receptor 3

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; BLOOD VESSEL; BREAST CARCINOMA; CANCER GRADING; CANCER TISSUE; CHI SQUARE TEST; DENSITY; FISHER EXACT TEST; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MICROVASCULATURE; MYOEPITHELIUM CELL; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

EID: 15944372668     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2004.11.008     Document Type: Article

References (34)

1. K. Alitalo P. Carmeliet Molecular mechanisms of lymphangiogenesis in health and disease Cancer Cell 1 2002 219-227
2. M.E. Baldwin B. Catimel E.C. Nice S. Roufail N.E. Hall K.l. Stenvers M.J. Karkkainen K. Alitalo S.A. Stacker M.G. Achen The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man J Biol Chem. 276 2001 19166-19171
3. G.H. Cunnick W.G. Jiang K.F. Gomez R.E. Mansel Lymphangiogenesis and breast cancer metastasis Histol. Histopathol. 17 2002 863-870
4. S.E. Duff C. Li M. Jeriorska S. Kumar M.P. Saunders D. Sherlock S.T. O'DWYEr G.C. Jayson Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy Br. J. Cancer 89 2003 426-430
5. C.W. Elston I.O. Ellis Pathological prognostic factors in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403-410
6. W. Fielder U. Graeven S. Ergun S. Verago N. Kilic M. Stockschlader D.K. Hossfeld Expression of FLT4 and its ligand VEGF-C in acute myeloid leukaemia Leukemia 11 1997 1234-1247
7. D.E. Hansel A. Rahman J. Hermans R.R. Krijger R. Ashfaq C.J. Yeo J.L. Cameron A. Maitra Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression Mod. Pathol. 16 2003 652-659
8. L. He M. Papoutsi R. Huang S.I. Tomarev B. Christ H. Kurz J. Wilting Three different fates of cells migrating from somites into the bud Anat. Embryol. (Berl.) 207 2003 29-34
9. R.K. Jain T.P. Padera Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy JNCI 94 2002 785-787
10. J. Jacquemier M.P. Mathoulin-Portier R. Valtola E. Charafe-Jauffret J. Geneix G. Houvenaeghel B. Puig V.I. Bardou J. Hassoun P. Viens D. Birnaum Prognosis of breast carcinoma lymphangiogenesis evaluated by immunohistochemical investigation of vascular endothelial growth factor receptor 3 Int. J. Cancer 89 2000 69-73
11. L. Jussila K. Alitalo Vascular growth factors and lymphangiogenesis Physiol. Rev. 82 2002 673-7000
12. T. Karpanen K. Alitalo Lymphatic vessels as targets of tumor therapy? J. Exp. Med. 194 2001 F37-F42
13. M. Younes R. Li T.M. Wheeler P. Scardino M. Ohori A. Frolov G. Ayala Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate Prostate 58 2004 193-199
14. A. Marinho R. Soares J. Ferro M. Lacerda F.C. Schmitt Angiogenesis in breast cancer is related to age but not to other prognostic parameters Pathol. Res. Pract. 193 1997 267-273
15. J.N. Mcginley K.K. Knott H.J. Thompson Semi-automated method of quantificatifying vasculature of 1-methyl-1-nitrosourea-induced rat mammary carcinomas using immunohistochemical detection J. Histoch. Cytoch. 50 2002 213-222
16. Y. Nakamura H. Yasuoka M. Tsujimoto Q. Yang S. Imabun M. Nakahara K. Nakao M. Nakamura I. Mori K. Kakudo Flt-4-positive vessel density correlates with vascular endothelial growth factor-D expression, nodal status and prognosis in breast cancer Clin. Cancer Res. 9 2003 5313-5317
17. S.D. Nathanson R.J. Zarbo D.L. Wachna C.A. Spence T.A. Andrzejewski J. Abrahms Microvessels that predict axillary lymph node metastases in patients with breast cancer Arch. Surg. 135 2000 586-594
18. G. Oliver Lymphatic vasculature development Nature Rev./Immunol. 4 2004 35-45
19. T.P. Padera A. Kadambi E. Di Tomaso C.M. Carreira E.B. Brown W. Boucher N.C. Choi D. Mathisen J. Wain E.J. Mark L.L. Munn R.K. Jain Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 2002 1883-1886
20. T.P. Padera B.R. Stoll J.B. Tooderman D. Capen E. Di Tommaso R.K. Jain Cancer cells compress intratumour vessels Nature 427 2004 695
21. T.A. Partanen J. Arola A. Saaristo L. Jussila A. Ora M. Miettinen S.A. Stacker M.G. Achen K. Alitalo VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues FASEB 14 2000 2087-2096
22. J.S. Reis-Filho F.C. Schmitt Lymphangiogenesis in tumours: What do we know? Microsc. Res. Tech. 60 2003 171-180
23. J. Rutanen P. Leppänen T.T. Tuomisto T.T. Rissanen M.O. Hiltunen I. Vajanto M. Niemi T. Häkkinen K. Karkola S.A. Stacker M.G. Achen K. Alitalo S. Ylä-Hertutuala Vascular endothelial growth factor-D expression in human atherosclerotic lesions Cardiovascular Res. 59 2003 971-979
24. P. Salven S. Mustjoki R. Alitalo A. Alitalo S. Rafili VEGFR-3 and CD133 identify a population of CD 34+ lymphatic/vascular endothelial precursor cells Blood 101 2003 168-172
25. F.C. Schmitt M.P. Ferreira MIB-1 is a suitable marker of proliferative activity in formalin-fixed, paraffin-embedded sections of breast cancer Int. J. Surg. Pathol. 2 1995 287-294
26. [26] S.F. Schoppmann R. Horvat P. Birner Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review) Oncol. Reports 9 2002 455-460
27. M. Skobe T. Hawighorst D.G. Jackson R. Prevo L. Janes P. Velasco L. Riccardi K. Alitalo K. Claffey M. Detmar Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nature Med. 2 2001 192-198
28. F.A. Tavassoli P. DeVille Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours 2003 IARC Press, WHO Lyon
29. R. Valtola P. Salven P. Heikkilä J. Taipela H. Joensuu M. Rehn T. Pihlajaniemi H. Weich R. De Waal K. Alitalo VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer Am. J. Pathol. 154 1999 1381-1390
30. T. Veikkola M. Lohela K. Ikenberg T. Mäkinen T. Korff A. Saaristo T. Petrova M. Jeltsch H.G. Augustin K. Alitalo Intrinsic versus microenviromental regulation of lymphatic endothelial cell phenotype and function FASEB 17 2003 2006-2013
31. World Health Organization Histological Typing of Breast Tumours Second ed. 1981 WHO Geneva
32. H. Winther A. Ahmed V. Dantzer Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two vascular endothelial receptors, Flt-1 and KDR, in the porcine placenta and non pregnant uterus Placenta 20 1999 35-43
33. A.N. Witmer B.C. Van Blijswijk J. Dai P. Hofman T.A. Partanen G.F.J.M. Vrensen R.O. Schlingermann VEGFR-3 in adult angiogenesis J. Pathol. 197 2001 490-497
34. D. Witte A. Thomas N. Ali N. Carlson M. Yuones Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGFR-C in human colorectal adenocarcinoma Anticancer Res. 22 2002 1463-1466